Jeremy Chadwick, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeremy Chadwick, Ph.D.
Jeremy Chadwick, Ph.D. is recorded as COO at Kymera Therapeutics, Inc. (KYMR). Kymera Therapeutics, Inc. reported in an 8-K filed May 22, 2023 that Jeremy Chadwick, Ph.D. was appointed Chief Operating Officer, effective May 22, 2023.
“On May 22, 2023, Kymera Therapeutics, Inc. (the "Company") announced the appointment of Jeremy Chadwick, Ph.D., as Chief Operating Officer effective as of May 22, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-05-22–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kymera Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Bruce Jacobs CFO
- Jeremy Chadwick COO
- Brian R. Adams General Counsel
- Brian R. Adams, J.D. General Counsel
- Bruce Booth Board Member
- Elena Ridloff Board Member
- Felix J. Baker, Ph.D. Board Member
- Gorjan Hrustanovic, Ph.D. Board Member
- John Maraganore Board Member
- Nello Mainolfi Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.